DJIA 17,719.92 -78.57 -0.44%
NASDAQ 5,108.67 -18.86 -0.37%
S&P 500 2,080.41 -9.70 -0.46%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

104.06 -3.32 (-3.09%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ALNY $104.06 -3.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $107.72
Previous Close $107.38
Daily Range $101.68 - $108.82
52-Week Range $71.14 - $140.00
Market Cap $8.8B
P/E Ratio -41.14
Dividend (Yield) $0.00 (0.0%)
Volume 665,097
Average Daily Volume 878,070
Current FY EPS -$3.38




Drug Makers

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website:

News & Commentary

These 3 Biotechs Are Winning in the Clinic

Here's the latest compelling data from Aimmune, Alnylam, and AstraZeneca.

Leerink Highlights Biotechs Poised To Benefit From ASH Conference

Clinton's Price Caps Are A Non-Starter: Liana Moussatos Of Wedbush Securities

Premarket Biotech Digest: Pfizergan, Gilead's Milestone, MannKind CEO Steps Down

Biotechs Go Low-Fat: Relevance To Amgen, Regeneron, The Medicines Company And Isis

Weekly Insider Sells Highlights: Facebook, PacWest Bancorp, Waste Management, Alnylam ...

Alnylam Pharmaceuticals, Inc. Earnings: 100% Positive (Data)

Without any sales, the biotech reiterates its positive pipeline record.

These 2 Companies Could Revolutionize Heart Disease Prevention

Early human clinical trial results suggest that a better drug for lowering bad cholesterol may be on the horizon.

Trade-Ideas: Alnylam Pharmaceuticals (ALNY) Is Today's "Dead Cat Bounce" Stock

Alnylam Pharmaceuticals Keeping Multiple High-Potential Programs Moving Forward

See More ALNY News...

ALNY's Top Competitors

ALNY $104.06 (-3.09%)
Current stock: ALNY
AMGN $161.10 (-1.48%)
Current stock: AMGN
GILD $105.96 (-1.89%)
Current stock: GILD
BIIB $286.86 (-2.17%)
Current stock: BIIB